Published in:
01-07-2017 | Brief Communication
Tumor treating fields in pediatric high-grade glioma
Authors:
Adam L. Green, Jean M. Mulcahy Levy, Rajeev Vibhakar, Molly Hemenway, Jennifer Madden, Nicholas Foreman, Kathleen Dorris
Published in:
Child's Nervous System
|
Issue 7/2017
Login to get access
Abstract
Purpose
Tumor treating fields (TTF) are alternating electric fields applied continuously to the scalp. The treatment is approved for both primary and recurrent supratentorial adult glioblastoma but unstudied in children.
Methods
We report a feasibility case series of five pediatric high-grade glioma patients (ages 10–20 years) treated at our institution with TTF along with chemotherapy and/or radiation.
Results
Two patients began therapy at second recurrence and showed progressive disease. Two others were treated upfront after radiation therapy, and both showed partial responses. A fifth patient was treated at first recurrence and also showed a partial response. All five tolerated TTF well without treatment-limiting toxicities.
Conclusions
The tolerability of TTF, combined with the adult data, justify a pediatric clinical trial.